An observational study in Perihilar Cholangiocarcinoma and Jaundice, Obstructive, sponsored by Central Hospital, Nancy, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-10-15.
Sponsored by Central Hospital, Nancy, France · Observational
This retrospective monocentric study aims at comparing multimodality endoscopic biliary drainage versus percutaneous radiologic biliary drainage in case of perihilar malignant obstruction.
Data from patients admitted in the Nancy University Hospital, France, between january 2016 and march 2022 with jaundice and perihilar obstruction will be retrospectively collected.
82 studies on the registry are indexed under Klatskin Tumor; 27 are open to participants now.
This study's planned enrollment of 100 is below the median of 200 across 23 observational studies indexed under Klatskin Tumor.
Browse Klatskin Tumor studies →Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.
Counted across the registry records on this site, refreshed daily.
all adults patients hospitalized in Nancy University Hospital with perihilar biliary malignant obstruction who underwent either endoscopic or percutaneous approach for biliary drainage.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All patients with perihilar malignant biliary obstruction treated with endoscopic drainage. This drainage can be multimodal using endoscopic retrograde cholangiopancreatography (ERCP) or endoscopic ultrasound (EUS)-guided biliary drainage.
Procedure: Endoscopic drainage
All patients with perihilar malignant biliary obstruction treated with percutaneous drainage
Procedure: Percutaneous transhepatic biliary drainage
ERCP and/or EUS-guided biliary drainage
US or CT-guided percutaneous drainage
Bilirubin serum level
Diminution of 20% of more on day 7 of the bilirubin serum level
Time frame: 7 days
Complications
complication-free survival
Time frame: 16 years
number of procedures
total number of procedures, including all endoscopic and radiological interventions
Time frame: 16 years
bilirubin serum level on day 30 and on day 90
Time frame: 90 days
median survival in months
median survival in month in each group
Time frame: 16 years
number of unplanned hospital admissions
total number of unplanned hospital admissions (for unplanned biliary drainage, cholangitis or other complications...)
Time frame: 16 years
This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France →